TM1 Forum

GTC Biotherapeutics, Inc. is a biotechnology company. GTC applies transgenic
animal technology in the development, production, and commercialization of
therapeutic proteins. The transgenic animals, typically goats, carry DNA designed to
produce therapeutic proteins during lactation. The milk is then purified into the final
product, which meets all the requirements for any biologic drug.

GTC uses IBM Cognos TM1 to convert strategy into detailed action plans. Used for both
in-house and third-party development projects, plans indicate how GTC development
activities convert into financial results. TM1 helps evaluate alternative approaches by
examining differing yield scenarios. GTC’s Senior Director of Financial Planning and
Analysis Jim Kneece notes that, “IBM Cognos TM1 allows us to integrate activity plans
from Microsoft® Project directly into our forecasting system, which allows us to model in
exactly the same way we do our work. We can clearly see what is driving our business
and the potential effects of different strategies.” He also notes that, “this planning tool
has created mutual value by linking the operational lines and finance.”